Paul Sorajja MD
Interventional Cardiology
Associate Director, Banner University Medicine Heart Institute Director, Interventional Cardiology and Structural Heart Disease, Banner University Medical Center - Phoenix Medical Director, Cardiac Cath Laboratory Lentsch Family Endowed Chair for Valve and Structural Heart Disease Professor of Medicine, University of Arizona College of Medicine
Join to View Full Profile
755 E McDowell RdFloor 4Phoenix, AZ 85006
Phone+1 602-521-3090
Fax+1 602-521-3661
Dr. Sorajja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Sorajja is a cardiologist in Phoenix, AZ, and is affiliated with Banner University Medical Center - Phoenix. He received his medical degree from Mayo Clinic School of Medicine and has been in practice over 25 years. He specializes in interventional cardiology, hypertrophic cardiomyopathy, structural heart therapy, and valvular heart disease.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Interventional Cardiology, 2004 - 2006- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2001 - 2005
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2000 - 2001
- Mayo Clinic College of MedicineClass of 1997
Certifications & Licensure
AZ State Medical License 2025 - 2026
MN State Medical License 1998 - 2026
FL State Medical License 2010 - 2015
LA State Medical License 2014 - 2014
American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Portico Next Generation Approval Study Start of enrollment: 2019 Sep 17
- MitraClip REPAIR MR Study Start of enrollment: 2020 Jul 21
- Join now to see all
Publications & Presentations
PubMed
- Transcatheter Mitral Valve Replacement for Severe Mitral Annular Calcification: Primary Outcomes from the SUMMIT-MAC Study.Paul Sorajja, Vinod H Thourani, Jason H Rogers, Brian Bethea, Mayra E Guerrero
Journal of the American College of Cardiology. 2025-10-27 - Tricuspid Anatomic Regurgitant Orifice Area by Cardiac Computed Tomography: Novel Outcome Insights.Davide Margonato, Bernardo B Lopes, Go Hashimoto, Miho Fukui, Asa Phichaphop
JACC. Cardiovascular Imaging. 2025-10-24 - Favorable Effects of Atrial Fixation Transcatheter Mitral Valve Replacement on Left Atrium Volume and Strain.Nadira Hamid, Paul Grayburn, Vlasis Ninios, Krzysztof Wrobel, Naeem Tahirkheli
JACC. Advances. 2025-10-16
Journal Articles
- Atrial Shunting for Heart FailurePeter M Eckman, Paul Sorajja, Michael A Samara, ScienceDirect
- Original Investigation Editorial Comment Searching for Surgical Alternatives in Hypertrophic Cardiomyopathy∗William T Katsiyiannis, Paul Sorajja, Kevin M Harris, ScienceDirect
- Prevalence, Trends, and Outcomes of Higher Risk Percutaneous Coronary Interventions Among Patients Without Acute Coronary Syndromes☆☆☆Ivan Chavez, M Nicholas Burke, Daniel Lips, Jay Traverse, Emmanouil S Brilakis, Anil Poulose, Michael Mooney, Paul Sorajja, Yale Wang, ScienceDirect
- Join now to see all
Lectures
- Once TMVR Is Refined, It Will Be the Preferred Therapy for Most MR PatientsCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019
Other
- Searching for Surgical Alternatives in Hypertrophic CardiomyopathyPaul Sorajja, MD, JACC: Cardiovascular Imaging
https://www.doximity.com/articles/7753abf6-8311-4177-8f60-04b04b5d00d8
UpToDate, Wolters Kluwer Health - 2013-03-18
Authored Content
- Hemodynamic Profiles and Clinical Response to Transcatheter Mitral RepairAugust 2022
- Searching for Surgical Alternatives in Hypertrophic CardiomyopathyOctober 2018
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- Early Experience with New Transcatheter Mitral Valve ReplacementJanuary 2018
- Join now to see all
Press Mentions
Tendyne Transcatheter Mitral Valve Replacement (TMVR) in Patients with Severe Mitral Annular Calcification (MAC) Found Effective and Safe: SUMMIT-MAC Trial, TCT 2025October 30th, 2025- Banner Cardiologist Creates New Valve Replacement DeviceOctober 28th, 2025
- New Transcatheter Mitral Valve Replacement System Offers Safe Treatment for High-Risk Patients with Severe Mitral Annular CalcificationOctober 28th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
